Release date: 2013-07-19 Source: Kexun Nucleic Acid Extractor NFAST 96 This nucleic acid extraction system is a biomedical instrument specially used for automatic magnetic bead method nucleic acid extraction. automatic nucleic acid extraction system,nucleic acid extraction instrument,nucleic acid extracting system,rna isolation machine,DNA extracting equipment Shenzhen Uni-medica Technology Co.,Ltd , https://www.unimed-global.com
At the 2013 International Biological Congress held recently, in the exhibition area of ​​a certain company, several media reporters were attracted by a blood pressure meter with only the size of the palm, and they measured their blood pressure before the booth. It is understood that this company has developed dozens of portable medical devices, as well as remote medical treatment devices, so that users can see a doctor at home without going out.
"China's medical device market has increased from 30 billion yuan to 160 billion yuan in the past 10 years, an increase of 20% to 25%." Academician of the Chinese Academy of Engineering and professor of Tsinghua University, Cheng Jing introduced in the report of the conference. Among them, the biochemical analyzer is a relatively high-end product. Future traditional, fast and high-end products and products that lead the trend of new technologies will coexist.
At present, China's fully automatic immunochemical analyzer is gradually shortening the distance from developed countries. The highest level of immunochemical analysis abroad can be analyzed about 200 times per hour. China currently has manufacturers who can analyze 100 to 200 samples per hour. From the perspective of global development, the devices for in vitro diagnostics of medical devices have also grown rapidly, mainly in three aspects: molecular diagnosis, pathological analysis and bedside monitoring.
Although the gap between domestically produced equipment related to molecular diagnostics is getting smaller and smaller compared with developed countries, the gap between high-end products is still large. In terms of sequencing instrument platform software, with the support of the Ministry of Science and Technology, only some enterprises and universities are currently involved in research. After a company received funding last year, this year produced a sequencer specifically for genetic mutation detection, but it has not been able to compete with foreign manufacturers.
According to statistics, in the first quarter of this year, China imported more than $3 billion worth of medical devices from 81 countries and regions, an increase of 15.41% year-on-year. Among them, Europe is China's largest import market for medical devices, with an import value of 1.171 billion US dollars, an increase of 16.42%; North America is the second largest market, with an import value of 1.003 billion US dollars, an increase of 16.52%; Asia ranks third, import value It was 820 million US dollars, an increase of 14.38%.
Among these imported products, the medical equipment used was $2.17 billion. Among the products with imported medical devices exceeding US$5,000, high value-added products mainly include color ultrasonic diagnostic equipment, X-ray tomograph, endoscope, complete MRI device, X-ray tube, vascular stent and artificial Joints, etc. Obviously, China's high-end medical device products are lacking, do not occupy the forefront of the international market, and do not have the right to speak in the market.
According to expert analysis, although “copy†can quickly produce products that are safe and effective, and can eliminate development time and cost, Chinese manufacturers still have gaps in “copy†products and genuine products due to insufficient manufacturing technology. The high-end market is competitive.
At the same time, China's large orthopaedic equipment companies have been merged by major US companies in recent years. These companies are not only to seize the Chinese market, but also set up R&D bases in China through mergers and acquisitions, so that most patients can receive medical care.
To this end, the orthopaedic expert suggested that in the case of China's industrial transformation, a national-level biomedical R&D center could be established to assist the industry to translate clinical innovation ideas and basic research results from academia into marketed products. This can avoid the industry's time and cost in a short period of time to explore the independent innovation of the research and development process, so that the industry to win time, gain the ability to innovate, and compete with major international manufacturers.
You only need to add the samples to be extracted to the matching kit, put the kit into the extraction machine, run the program that comes with the instrument, and complete a round of extraction of 96 nucleic acid samples in 9 minutes.
The unique cryopreservation function of our NFAST 96 nucleic acid extraction system can ensure the quality of the extracted product when you cannot process the extracted nucleic acid in time.